Different gene loci within the HLA-DR and TNF regions are independently associated with susceptibility and severity in Spanish rheumatoid arthritis patients.
暂无分享,去创建一个
W. Thomson | W. Ollier | A. Hajeer | M. González-Gay | D. Mattey | K. Poulton | W E Ollier | W Thomson | C García-Porrúa | K Poulton | A H Hajeer | A Dababneh | R F Makki | M A González-Gay | D L Mattey | C. García‐Porrúa | A. Dababneh | R. Makki
[1] A. Cambon-Thomsen,et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF‐a and TNF‐0 by human mononuclear cells: a possible link to insulin‐dependent diabetes mellitus , 1993 .
[2] W. Ollier,et al. HLA and rheumatoid arthritis: susceptibility or severity? , 1986, Disease markers.
[3] I. Bruce,et al. Genetic analysis of multiplex rheumatoid arthritis families , 1999, Genes and Immunity.
[4] P. Gregersen,et al. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. , 1987, Arthritis and rheumatism.
[5] Differential associations of HLA-DR antigens with rheumatoid arthritis (RA) in Basques: high frequency of DR1 and DR10 and lack of association with HLA-DR4 or any of its subtypes. , 1994, Tissue antigens.
[6] A. Silman,et al. HLA-DRB1*0401/0404 genotype and rheumatoid arthritis: increased association in men, young age at onset, and disease severity. , 1995, The Journal of rheumatology.
[7] P. Stastny. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. , 1978, The New England journal of medicine.
[8] C. Amos,et al. Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis. , 1996, American journal of human genetics.
[9] H. Mcdevitt,et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[10] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.
[11] M. González-Gay,et al. Could HLA-DRB1 be the protective locus in rheumatoid arthritis? , 1995, Immunology today.
[12] M. Feldmann,et al. Role of cytokines in rheumatoid arthritis. , 1996, Annual review of immunology.
[13] A. Silman,et al. Association of tumor necrosis factor microsatellite polymorphisms with HLA-DRB1*04-bearing haplotypes in rheumatoid arthritis patients. , 1996, Arthritis and rheumatism.
[14] J. Yélamos,et al. Association of HLA-DR4-Dw15 (DRB1*0405) and DR10 with rheumatoid arthritis in a Spanish population. , 1993, Arthritis and rheumatism.
[15] G. Strassmann,et al. Mutational analysis of TNF-alpha gene reveals a regulatory role for the 3'-untranslated region in the genetic predisposition to lupus-like autoimmune disease. , 1996, Journal of immunology.
[16] J. Yélamos,et al. Association of the shared epitope with radiological severity of rheumatoid arthritis. , 1996, The Journal of rheumatology.
[17] Paul Wordsworth,et al. HLA heterozygosity contributes to susceptibility to rheumatoid arthritis. , 1992, American journal of human genetics.
[18] S. Bonanad,et al. HLA-DQA, -DQB and -DRB allele contribution to narcolepsy susceptibility. , 1997, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.
[19] J. Woody,et al. Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis , 1994, The Lancet.